Literature DB >> 18981578

The Kampo medicines Orengedokuto, Bofutsushosan and Boiogito have different activities to regulate gene expressions in differentiated rat white adipocytes: comprehensive analysis of genetic profiles.

Jun-ichi Yamakawa1, Yasuhito Ishigaki, Fumihide Takano, Takashi Takahashi, Junko Yoshida, Junji Moriya, Takanobu Takata, Takanori Tatsuno, Kenroh Sasaki, Tomihisa Ohta, Tsutomu Takegami, Fumihiko Yoshizaki.   

Abstract

Three Kampo medicines, Boiogito (BOT), Bofutsushosan (BTS) and Orengedokuto (OGT), used for obese patients were investigated for their effects on adipogenesis in cultured rat white adipocytes. Administration of the three extracts suppressed adipogenesis in concentration-dependent manners (1-100 microg/ml) without any cytotoxicity. Changes in mRNA expression levels were analyzed using a Rat 230 2.0 Affymetrix GeneChip microarray system. DNA microarray analysis (total probe set: 31099) using cDNAs prepared from adipocytes revealed that BOT, BTS and OGT increased the expression of 133-150 genes and decreased the expression of 42-110 genes by > or =2-fold. We identified 329 downregulated genes and 189 upregulated genes among a total set of 514 probes (overlap: 4). Overall, genes related to cellular movement, cell death, cell growth/differentiation and immune responses were the most downregulated, while those related to lipid metabolism and cell signaling were the most upregulated. Semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assays were conducted to confirm the microarray results. Analysis of the clustering profiles of the microarray results revealed that BOT and BTS changed the expression levels of similar genes mainly involved in small molecule biochemistry and cell differentiation, while OGT altered 10 genes related to lipid metabolism, in contrast to the effects of BOT and BTS. We also measured mRNA expression levels of seven selected genes highly contributing to the lipid metabolism by using semiquantitative RT-PCR assay, that were acetyl-Coenzyme A carboxylase alpha (ACACA), AE binding protein 1 (AEBP1), patatin-like phospholipase domain containing 8 (PNPLA8), secretoglobin (SCGB1A1), adrenergic (ADRB3), adiponectin (ADIPOQ), monoglyceride lipase (MGLL). Beta-actin (ACTB) gene was used as an endogenous internal standard. The present findings indicate that these three herbal extracts have the potential to prevent adipogenesis in rat white adipocytes through different mechanisms via modulation of gene expression levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981578     DOI: 10.1248/bpb.31.2083

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial.

Authors:  Junghyun Park; Shambhunath Bose; Sun-Woo Hong; Dong-Ki Lee; Jae-Wook Yoo; Chi-Yeon Lim; Myeongjong Lee; Hojun Kim
Journal:  J Med Food       Date:  2014-05       Impact factor: 2.786

2.  Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence.

Authors:  Jun-Ichi Yamakawa; Junji Moriya; Kenji Takeuchi; Mio Nakatou; Yoshiharu Motoo; Junji Kobayashi
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

3.  Role of Kampo medicine in integrative cancer therapy.

Authors:  Jun-Ichi Yamakawa; Yoshiharu Motoo; Junji Moriya; Masao Ogawa; Hiroaki Uenishi; Sumiyo Akazawa; Toshiyuki Sasagawa; Matomo Nishio; Junji Kobayashi
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-22       Impact factor: 2.629

4.  Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice.

Authors:  Masafumi Ono; Mitsunari Ogasawara; Akira Hirose; Sachiko Mogami; Nobuhiro Ootake; Kosuke Aritake; Takuma Higuchi; Nobuto Okamoto; Shuji Sakamoto; Masahiro Yamamoto; Yoshihiro Urade; Toshiji Saibara; Jude A Oben
Journal:  J Gastroenterol       Date:  2013-06-26       Impact factor: 7.527

5.  Hwangryunhaedok-tang induces the depolarization of pacemaker potentials through 5-HT3 and 5-HT4 receptors in cultured murine small intestine interstitial cells of Cajal.

Authors:  Hyun Jung Kim; Guem San Lee; Hyungwoo Kim; Byung Joo Kim
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

6.  Effects of Hwangryunhaedok-tang on gastrointestinal motility function in mice.

Authors:  Hyoyeon Kim; Iksung Kim; Min Cheol Lee; Hyun Jung Kim; Guem San Lee; Hyungwoo Kim; Byung Joo Kim
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

Review 7.  DNA Microarray-Based Screening and  Characterization of Traditional Chinese Medicine.

Authors:  Ryoiti Kiyama
Journal:  Microarrays (Basel)       Date:  2017-01-30

8.  Inhibitory Effects of Hwangryunhaedok-Tang in 3T3-L1 Adipogenesis by Regulation of Raf/MEK1/ERK1/2 Pathway and PDK1/Akt Phosphorylation.

Authors:  Dong Hoon Kwak; Ji-Hye Lee; Dong-Gun Kim; Taesoo Kim; Kwang Jin Lee; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-23       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.